FDA speed
Post# of 150221
(Total Views: 445)
Posted On: 02/08/2021 11:40:42 AM
Re: KenChowder #76771
Remember when this was stated:
Marty Makary, a professor at the Johns Hopkins University School of Medicine and Johns Hopkins Bloomberg School of Public Health, has criticized the U.S. Food and Drug Administration (FDA) for its slow approval process of Pfizer's COVID-19 vaccine, saying that such approval could be completed in an hour.
"As Pfizer's application sits on the shelf at the FDA awaiting authorization, about 27,000 Americans will have died," Makary wrote, saying if his data analysis team needed to review Pfizer's vaccine study of 43,000 patients, "it would take about one hour."
He said his team of 14 research could doctors go through all the potential Covid 19 drugs in two weeks.
Marty Makary, a professor at the Johns Hopkins University School of Medicine and Johns Hopkins Bloomberg School of Public Health, has criticized the U.S. Food and Drug Administration (FDA) for its slow approval process of Pfizer's COVID-19 vaccine, saying that such approval could be completed in an hour.
"As Pfizer's application sits on the shelf at the FDA awaiting authorization, about 27,000 Americans will have died," Makary wrote, saying if his data analysis team needed to review Pfizer's vaccine study of 43,000 patients, "it would take about one hour."
He said his team of 14 research could doctors go through all the potential Covid 19 drugs in two weeks.
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼